These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17012652)

  • 1. Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations.
    Gilbody S; Bower P; Whitty P
    Br J Psychiatry; 2006 Oct; 189():297-308. PubMed ID: 17012652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.
    Simon GE; Katon WJ; VonKorff M; Unützer J; Lin EH; Walker EA; Bush T; Rutter C; Ludman E
    Am J Psychiatry; 2001 Oct; 158(10):1638-44. PubMed ID: 11578996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of collaborative care for depression in a primary care veteran population.
    Liu CF; Hedrick SC; Chaney EF; Heagerty P; Felker B; Hasenberg N; Fihn S; Katon W
    Psychiatr Serv; 2003 May; 54(5):698-704. PubMed ID: 12719501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of a collaborative care programme for depression in primary care.
    Aragonès E; López-Cortacans G; Sánchez-Iriso E; Piñol JL; Caballero A; Salvador-Carulla L; Cabasés J
    J Affect Disord; 2014 Apr; 159():85-93. PubMed ID: 24679395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
    Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
    Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.
    Johnson JA; Lier DA; Soprovich A; Al Sayah F; Qiu W; Majumdar SR
    Am J Prev Med; 2016 Jul; 51(1):e13-20. PubMed ID: 26947212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of on-site versus off-site collaborative care for depression in rural FQHCs.
    Pyne JM; Fortney JC; Mouden S; Lu L; Hudson TJ; Mittal D
    Psychiatr Serv; 2015 May; 66(5):491-9. PubMed ID: 25686811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economics of collaborative care for management of depressive disorders: a community guide systematic review.
    Jacob V; Chattopadhyay SK; Sipe TA; Thota AB; Byard GJ; Chapman DP;
    Am J Prev Med; 2012 May; 42(5):539-49. PubMed ID: 22516496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of treatments for major depression in primary care practice.
    Lave JR; Frank RG; Schulberg HC; Kamlet MS
    Arch Gen Psychiatry; 1998 Jul; 55(7):645-51. PubMed ID: 9672056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.
    Katon W; Unützer J; Fan MY; Williams JW; Schoenbaum M; Lin EH; Hunkeler EM
    Diabetes Care; 2006 Feb; 29(2):265-70. PubMed ID: 16443871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care.
    Simon GE; Manning WG; Katzelnick DJ; Pearson SD; Henk HJ; Helstad CS
    Arch Gen Psychiatry; 2001 Feb; 58(2):181-7. PubMed ID: 11177120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
    Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
    Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.
    Clegg AJ; Loveman E; Gospodarevskaya E; Harris P; Bird A; Bryant J; Scott DA; Davidson P; Little P; Coppin R
    Health Technol Assess; 2010 Jun; 14(28):1-192. PubMed ID: 20546687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials.
    Neumeyer-Gromen A; Lampert T; Stark K; Kallischnigg G
    Med Care; 2004 Dec; 42(12):1211-21. PubMed ID: 15550801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a program to prevent depression relapse in primary care.
    Simon GE; Von Korff M; Ludman EJ; Katon WJ; Rutter C; Unützer J; Lin EH; Bush T; Walker E
    Med Care; 2002 Oct; 40(10):941-50. PubMed ID: 12395027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counseling versus antidepressant therapy for the treatment of mild to moderate depression in primary care: economic analysis.
    Miller P; Chilvers C; Dewey M; Fielding K; Gretton V; Palmer B; Weller D; Churchill R; Williams I; Bedi N; Duggan C; Lee A; Harrison G
    Int J Technol Assess Health Care; 2003; 19(1):80-90. PubMed ID: 12701941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.